Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE: 002773)
Health Care · Pharmaceuticals · CN
CN¥21.11
-6.80% today · -50.5% 1Y
Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE: 002773) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.89B and employs 4,470 people.
Over the last twelve months the share price has lost 50.5%, trading between 18.97 and 43.88.
Tweenvest scores Chengdu Kanghong Pharmaceutical Group Co., Ltd across four factors: quality 78/100, value 53/100, growth 65/100, dividend 77/100. Its strongest factor is quality.
002773 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.89B
- Revenue (TTM)
- $642.69M
- P/E
- 18.21
- EPS
- 1.16
- Dividend yield
- 3.32%
- Beta (5Y)
- -0.19
- 52-week high
- CN¥43.88
- 52-week low
- CN¥18.97
- Avg volume (3M)
- —
- Shares outstanding
- 921.33M
- Employees
- 4,470
- Next earnings
- —
About Chengdu Kanghong Pharmaceutical Group Co., Ltd
Chengdu Kanghong Pharmaceuticals Group Co., Ltd operates within China, focusing on the research, development, production, and marketing of a wide array of pharmaceutical goods. These include biologics, traditional Chinese medicines, and chemical drugs. The company's offerings span treatments for ophthalmic ailments, central nervous system conditions, digestive disorders, and other therapeutic areas. Founded in 1996, its corporate headquarters are located in Chengdu, China.
- ISIN
- CNE1000020C4
- Founded
- 1996
- Listed since
- Jun 29, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.